SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Wheelock M)
 

Search: WFRF:(Wheelock M) > (2020-2024) > ELIXIR and Toxicolo...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00005638naa a2201057 4500
001oai:DiVA.org:uu-485906
003SwePub
008220929s2021 | |||||||||||000 ||eng|
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4859062 URI
024a https://doi.org/10.12688/f1000research.74502.12 DOI
040 a (SwePub)uu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Martens, Marvin4 aut
2451 0a ELIXIR and Toxicology :b a community in development
264 c 2021-11-08
264 1b F1000 Research Ltd,c 2021
338 a electronic2 rdacarrier
520 a Toxicology has been an active research field for many decades, with academic, industrial and government involvement. Modern omics and computational approaches are changing the field, from merely disease-specific observational models into target-specific predictive models. Traditionally, toxicology has strong links with other fields such as biology, chemistry, pharmacology and medicine. With the rise of synthetic and new engineered materials, alongside ongoing prioritisation needs in chemical risk assessment for existing chemicals, early predictive evaluations are becoming of utmost importance to both scientific and regulatory purposes. ELIXIR is an intergovernmental organisation that brings together life science resources from across Europe. To coordinate the linkage of various life science efforts around modern predictive toxicology, the establishment of a new ELIXIR Community is seen as instrumental. In the past few years, joint efforts, building on incidental overlap, have been piloted in the context of ELIXIR. For example, the EU-ToxRisk, diXa, HeCaToS, transQST, and the nanotoxicology community have worked with the ELIXIR TeSS, Bioschemas, and Compute Platforms and activities. In 2018, a core group of interested parties wrote a proposal, outlining a sketch of what this new ELIXIR Toxicology Community would look like. A recent workshop (held September 30th to October 1st, 2020) extended this into an ELIXIR Toxicology roadmap and a shortlist of limited investment-high gain collaborations to give body to this new community. This Whitepaper outlines the results of these efforts and defines our vision of the ELIXIR Toxicology Community and how it complements other ELIXIR activities.  
650 7a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Farmakologi och toxikologi0 (SwePub)301022 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Pharmacology and Toxicology0 (SwePub)301022 hsv//eng
653 a Bioinformatics
653 a Bioinformatik
700a Stierum, Rob4 aut
700a Schymanski, Emma L.4 aut
700a Evelo, Chris T.4 aut
700a Aalizadeh, Reza4 aut
700a Aladjov, Hristo4 aut
700a Arturi, Kasia4 aut
700a Audouze, Karine4 aut
700a Babica, Pavel4 aut
700a Berka, Karel4 aut
700a Bessems, Jos4 aut
700a Blaha, Ludek4 aut
700a Bolton, Evan E.4 aut
700a Cases, Montserrat4 aut
700a Damalas, Dimitrios Ε.4 aut
700a Dave, Kirtan4 aut
700a Dilger, Marco4 aut
700a Exner, Thomas4 aut
700a Geerke, Daan P.4 aut
700a Grafström, Roland4 aut
700a Gray, Alasdair4 aut
700a Hancock, John M.4 aut
700a Hollert, Henner4 aut
700a Jeliazkova, Nina4 aut
700a Jennen, Danyel4 aut
700a Jourdan, Fabien4 aut
700a Kahlem, Pascal4 aut
700a Klanova, Jana4 aut
700a Kleinjans, Jos4 aut
700a Kondic, Todor4 aut
700a Kone, Boï4 aut
700a Lynch, Iseult4 aut
700a Maran, Uko4 aut
700a Martinez Cuesta, Sergio4 aut
700a Ménager, Hervé4 aut
700a Neumann, Steffen4 aut
700a Nymark, Penny4 aut
700a Oberacher, Herbert4 aut
700a Ramirez, Noelia4 aut
700a Remy, Sylvie4 aut
700a Rocca-Serra, Philippe4 aut
700a Salek, Reza M.4 aut
700a Sallach, Brett4 aut
700a Sansone, Susanna-Assunta4 aut
700a Sanz, Ferran4 aut
700a Sarimveis, Haralambos4 aut
700a Sarntivijai, Sirarat4 aut
700a Schulze, Tobias4 aut
700a Slobodnik, Jaroslav4 aut
700a Spjuth, Ola,c Professor,d 1977-u Uppsala universitet,Institutionen för farmaceutisk biovetenskap,Science for Life Laboratory, SciLifeLab4 aut0 (Swepub:uu)olspj499
700a Tedds, Jonathan4 aut
700a Thomaidis, Nikolaos4 aut
700a Weber, Ralf J.M.4 aut
700a van Westen, Gerard J.P.4 aut
700a Wheelock, Craig E.4 aut
700a Williams, Antony J.4 aut
700a Witters, Hilda4 aut
700a Zdrazil, Barbara4 aut
700a Županič, Anže4 aut
700a Willighagen, Egon L.4 aut
710a Uppsala universitetb Institutionen för farmaceutisk biovetenskap4 org
773t F1000 Researchd : F1000 Research Ltdg 10, s. 1129-1129q 10<1129-1129x 2046-1402
856u https://doi.org/10.12688/f1000research.74502.1y Fulltext
856u https://uu.diva-portal.org/smash/get/diva2:1699798/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
856u https://f1000research.com/articles/10-1129/v1/pdf
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-485906
8564 8u https://doi.org/10.12688/f1000research.74502.1

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view